Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

TACROLIMUS\TACROLIMUS ANHYDROUS for Colitis ulcerative: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 74 adverse event reports in the FDA FAERS database where TACROLIMUS\TACROLIMUS ANHYDROUS was used for Colitis ulcerative.

Most Reported Side Effects for TACROLIMUS\TACROLIMUS ANHYDROUS

Side Effect Reports % Deaths Hosp.
Off label use 708 10.4% 67 192
Death 321 4.7% 321 34
Transplant rejection 278 4.1% 18 50
Diarrhoea 257 3.8% 23 152
Pyrexia 243 3.6% 20 134
Alopecia 232 3.4% 0 6
Drug ineffective 198 2.9% 12 41
Transplant dysfunction 198 2.9% 2 15
Hospitalisation 194 2.9% 12 192
Pneumonia 193 2.8% 35 116
Acute kidney injury 185 2.7% 35 150
Renal impairment 185 2.7% 33 89
Nausea 170 2.5% 6 66
Vomiting 170 2.5% 8 91
Acne 169 2.5% 0 2

Other Indications for TACROLIMUS\TACROLIMUS ANHYDROUS

Renal transplant (1,368) Product used for unknown indication (1,105) Liver transplant (756) Prophylaxis against transplant rejection (578) Rheumatoid arthritis (378) Heart transplant (269) Immunosuppression (264) Immunosuppressant drug therapy (257) Transplant (235) Lung transplant (195)

Other Drugs Used for Colitis ulcerative

ADALIMUMAB (34,530) VEDOLIZUMAB (33,987) INFLIXIMAB (21,373) INFLIXIMAB-DYYB (6,767) TOFACITINIB (6,358) MESALAMINE (6,347) UPADACITINIB (4,800) USTEKINUMAB (3,872) GOLIMUMAB (3,637) HUMIRA (2,707)

Related Pages

TACROLIMUS\TACROLIMUS ANHYDROUS Full Profile All Colitis ulcerative Drugs TACROLIMUS\TACROLIMUS ANHYDROUS Demographics TACROLIMUS\TACROLIMUS ANHYDROUS Timeline